Neurological Disorder

An estimated 55.8 million patients presented to U.S. emergency departments from 2016 to 2019 with a neurological complaint as the primary reason for their visit, researchers reported in JAMA Neurology.

The FDA has granted breakthrough device designation to neurotechnology company Axoft for its brain-machine interface to treat long-term neurological disorders.

The Patient Health Questionnaire-9 appeared reliable and valid for depression screening among patients with neurological disorders, according to study results published in BMC Psychiatry.

The World Federation of Neurology has launched the Brain Health Initiative, a program intended to help reduce global burden of brain diseases and disorders.

In this video from the Annual Meeting of the American Neurological Association, Justin C. McArthur, MBBS, MPH, discussed the Presidential Symposium, “COVID-19 Pandemic: Population Impact and Responses, and Neurological Complications.”

Children with severe neurological impairment who had higher scores on the Medication Regimen Complexity Index were more likely to receive many more doses of medications per day from their parents, according to a cross-sectional study.

Individuals with a history of a neurological disorder prior to COVID-19 infection experienced an increased likelihood of acute care hospital re-encounters at both 30 days and 4 months, according to findings published in GeroScience.

The FDA announced that it has granted accelerated approval for viltolarsen, an injection to treat Duchenne muscular dystrophy in those with a confirmed mutation.

Researchers observed a U-shaped trend in age-adjusted mortality rates from neurological disorders from 1999 to 2017. The recent upward trend suggests these disorders are an “imminent threat to public health,” they wrote in JAMA Neurology.

A review in JAMA Neurology concluded that clinicians should monitor patients with COVID-19 for neurological disorders, but more research is needed to further examine the role of SARS-CoV-2 as a contributor to postinfectious neurologic complications, one of the review’s authors told Healio Primary Care.